Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00189449 · ClinicalTrials.gov registry record
Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis
A clinical trial, sponsored by West Penn Allegheny Health System.
- Completed
- Registry status
NCT00189449: Completed study, sponsored by West Penn Allegheny Health System.
NCT00189449 is a clinical trial that has completed, run by West Penn Allegheny Health System. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00189449 has completed, sponsored by West Penn Allegheny Health System.
- COMPLETED
- Registry status
Study Summary
Seasonal/perennial allergic rhinitis (SAR/PAR) is a common childhood illness. One of the leading therapies for the treatment of SAR/PAR is intranasally inhaled corticosteroids (ICS). One of the major long-term safety concerns is whether ICS interferes with normal growth in allergic rhinitis children. Recent evidence suggests that nasal ICS may cause decreased growth. However, the effect of nasal ICS on long-term growth and the attainment of final adult height is unknown. Another potential systemic adverse effect of ICS use is suppression of the hypothalamic-pituitary-adrenal axis function. The primary hypothesis of this study is that triamcinolone acetonide aqueous nasal spray (TAA) will have no effect on measured adult height in relation to target adult height in children with allergic rhinitis.
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2007-06 |
What the finished NCT00189449 record still lists
NCT00189449 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00189449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00189449 about?
NCT00189449 is a clinical study titled "Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis". Seasonal/perennial allergic rhinitis (SAR/PAR) is a common childhood illness. One of the leading therapies for the treatment of SAR/PAR is intranasally inhaled corticosteroids (ICS). One of the major long-term safety concerns is whether ICS interferes with normal growth in allergic rhinitis children...
What is the current status of trial NCT00189449?
This trial is currently completed. Estimated completion is 2007-06.
Who is sponsoring clinical trial NCT00189449?
This trial is sponsored by West Penn Allegheny Health System, which has 14 total clinical trials registered on ClinicalTrials.gov.